Clinical Pharmacology Archives | 第 9 页，共 10 页 | Certara

Blog

Using a Pharmacology to Payer Framework to Support Product Development

Modeling and simulation (M&S) of complex systems has primarily advanced vertically in differing scientific domains…

Certara2018 年 3 月 16 日

Publication

Cost-utility Analysis of Antiviral Use Under Pandemic Influenza Using a Novel Approach—Linking Pharmacology, Epidemiology and Heath Economics

Certara2018 年 3 月 1 日

Blog

勘测全球范围监管申请建模与模拟的现状

Analogous to how a geologist surveys the “lay of the land” to determine if oil…

Certara2018 年 2 月 16 日

Publication

Clinical Pharmacology Tools and Evaluations to Facilitate Comprehensive Dose Finding in Oncology: A Continuous Risk-Benefit Approach

Certara2017 年 9 月 15 日

White Paper

药物资产评估：提高交易的 "成功概率”

Certara’s due diligence/asset evaluation teams are comprised of drug development and commercialization experts who advise…

Certara2017 年 8 月 24 日

Brochure

研究用药物差距分析

As the process of drug development has increased in cost and complexity, Certara has developed…

Certara2017 年 8 月 14 日

Press Coverage

临床药理学 – 药物开发的关键

Clinical pharmacology accounts for about 50% of a drug label. Its scope ranges from facilitating…

Certara2017 年 8 月 14 日

Blog

注意差距：临床药理学差距分析最佳实践

您是否对参加考试感到焦虑？Many people do because they want to show…

Certara2017 年 5 月 25 日

Publication

A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-nucleoside Polymerase Inhibitor

Certara2017 年 1 月 10 日

Publication

Lessons Learned: Dose Selection of Small Molecule-targeted Oncology Drugs

Certara2016 年 6 月 1 日

© 2025 Certara. 保留所有权力。 | 隐私政策

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software